@inbook{a20c7f56f3634328b18184d81a8f6eaa,
title = "Conclusion",
author = "Lisa Jacobs and Finlayson, \{Christina A.\}",
note = "Funding Information: The importance and impact of well-conducted research trials are seen throughout the chapters of this book. Clinical trials conducted regarding prevention, imaging and early detection, local and systemic therapies, and quality of life have defined and redefined optimal care for patients and providers grappling with this disease. Funding for these clinical trials comes from many sources, including government funding agencies and private foundations. Recent financial reports indicate that annually the National Cancer Institute (NCI) sponsors \$573 million in breast cancer research funding, the Department of Defense \$138 million, 2 the Komen Foundation \$64 million, 3 and the Avon Foundation \$14 million. 4 Many other organizations large and small provide direct and indirect support for breast cancer research as well as additional monies to support education, public awareness, and direct patient care services. A significant portion of these funds comes from the generous donations of private citizens, many of whom have had personal experience with breast cancer and who want to do their part to help others in their community who have been touched by this disease. ",
year = "2010",
month = jul,
day = "15",
doi = "10.1016/B978-1-4160-4932-6/50030-5",
language = "English (US)",
isbn = "9781416049326",
pages = "363--365",
booktitle = "Early Diagnosis and Treatment of Cancer Series",
publisher = "Elsevier",
}